† 1,2

* Terms and conditions apply , please call 01344 746960 ( UK ) or 01 291 3985 ( Ireland ) or email vetenquiries @ boehringer-ingelheim . com for more information and to access a copy .

†

9 out of 10 dogs that demonstrated a preference in the studies preferred NexGard Spectra ® . References : 1 . Perier N , Carithers DS , Everett WR , et al . Preference of Dogs between Two Oral Formulations of Endectoparasiticides : NexGard Spectra ® ( Afoxolaner and Milbemycin Oxime ) and Simparica Trio™ ( Sarolaner , Moxidectin and Pyrantel ). Open Journal of Veterinary Medicine 2020 ; 10:155-163 . 2 . Perier N , Carithers DS , Everett WR , et al . Preference in Dogs of Two Oral Endectoparasiticide Formulations : NexGard Spectra ® ( Afoxolaner and Milbemycin Oxime ) and Credelio ® Plus ( Lotilaner and Milbemycin Oxime ). Open Journal of Veterinary Medicine 2021 ; 11:289-298 . NexGard Spectra ® contains afoxolaner and milbemycin oxime . UK : POM-V IE : POM . Further information available in the SPC or from Boehringer Ingelheim Animal Health UK Ltd ., RG12 8YS , UK . UK Tel : 01344 746959 ( sales ) or 01344 746957 ( technical ), IE Tel : 01 291 3985 ( all queries ). Email : vetenquiries @ boehringer-ingelheim . com . NexGard Spectra ® is a registered trademark of Boehringer Ingelheim Animal Health France SCS , used under licence . © 2023 Boehringer Ingelheim Animal Health UK Ltd . All rights reserved . Date of preparation : April 2023 . UI-CAN-0039-2023 . Use Medicines Responsibly .